Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-24 12:27 pm Sale | 2023-02-22 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 223,500 4.780% | -29,333 (-11.60%) | Filing History |
| 2023-01-31 11:59 am Unchanged | 2023-01-25 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 252,833 4.120% | 0 (Unchanged) | Filing History |
| 2022-01-11 12:04 pm Purchase | 2022-01-10 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 252,833 6.030% | 44,500 (+21.36%) | Filing History |
| 2021-12-15 12:52 pm Sale | 2021-12-14 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 208,333 4.970% | -35,786 (-14.66%) | Filing History |
| 2021-12-15 12:42 pm Sale | 2021-12-14 | 13D | Reed's, Inc. REED | FiveT Investment Management Ltd | 93,000 4.960% | -8,502 (-8.38%) | Filing History |
| 2021-06-21 12:01 pm Purchase | 2021-06-16 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 244,119 5.830% | 244,119 (New Position) | Filing History |
| 2021-05-25 1:15 pm Unchanged | 2021-05-05 | 13D | Cocrystal Pharma, Inc. COCP | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-05-25 1:11 pm Purchase | 2021-05-05 | 13D | Reed's, Inc. REED | FiveT Investment Management Ltd | 101,502 5.420% | 101,502 (New Position) | Filing History |
| 2021-04-27 1:13 pm Purchase | 2021-04-26 | 13D | GEE Group, Inc. JOB | FiveT Investment Management Ltd | 4,957,500 4.680% | 4,957,500 (New Position) | Filing History |
| 2021-02-25 3:22 pm Purchase | 2021-02-11 | 13D | Pulmatrix, Inc. PULM | FiveT Investment Management Ltd | 46,447 1.660% | 46,447 (New Position) | Filing History |
| 2021-02-25 3:14 pm Unchanged | 2021-02-10 | 13D | Neovasc Inc. NVCN | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-25 3:05 pm Unchanged | 2021-02-11 | 13D | CANCER GENETICS INC CGIX | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-25 2:55 pm Unchanged | 2021-02-17 | 13D | AIkido Pharma Inc. AIKI | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-19 12:25 pm Unchanged | 2021-01-29 | 13D | ALT5 Sigma Corporation ALTS | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | Filing History |